MyFinsight
Home
About
Contact
Back
Income Statement
ABVC BIOPHARMA, INC. (ABVC)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$2,217,382
(-173.73%↓ Y/Y)
Foreign currency
translation adjustment
$39,640
(-80.43%↓ Y/Y)
Net loss attributed
to abvc and...
-$2,257,022
Net loss
attributable to...
-$75,811
(70.85%↑ Y/Y)
Net loss
-$2,332,833
(-83.30%↓ Y/Y)
Loss before
provision income tax
-$2,309,206
(-66.90%↓ Y/Y)
Provision for income tax
expense
$23,627
(121.31%↑ Y/Y)
Total other expenses
-$14,223
(96.50%↑ Y/Y)
Loss from operations
-$2,294,983
(-134.99%↓ Y/Y)
Operating sublease income
$12,000
Gain (loss) on
foreign exchange
$136,148
(215.71%↑ Y/Y)
Interest income
$19,139
(-29.48%↓ Y/Y)
Loss on investment in
equity securities
-$44,917
Total operating
expenses
$2,294,983
(109.86%↑ Y/Y)
Interest expense
$129,413
(-50.23%↓ Y/Y)
Other income
(expenses)
-$7,180
(-132.35%↓ Y/Y)
Research and development
expenses
$33,276
(-17.64%↓ Y/Y)
Selling, general and
administrative expenses
$690,094
(7.75%↑ Y/Y)
Stock-based compensation
$1,571,613
(280.77%↑ Y/Y)
Back